Literature DB >> 17188265

ADP ribosylation factor like 2 (Arl2) protein influences microtubule dynamics in breast cancer cells.

Anne Beghin1, Stephane Honore, Celine Messana, Eva-Laure Matera, Jennifer Aim, Sandrine Burlinchon, Diane Braguer, Charles Dumontet.   

Abstract

ADP ribosylation factor like 2 (Arl2) protein is involved in the folding of tubulin peptides. Variants of the human adenocarcinoma line MCF7 cells with increased or reduced content of Arl2 protein were produced and characterized. Western blot analysis performed after separation of the different fractions of tubulins showed that the content in polymerizable soluble heterodimers was significantly increased in cells with the highest Arl2 expression level (MA+) and reduced in cells with the lowest Arl2 expression level (MA-) in comparison to control cells (MP). Microtubule dynamic instability, measured after microinjection of rhodamine-labelled tubulin in living cells, was significantly enhanced in MA+ cells and reduced in MA- cells. These alterations involved modifications of the microtubule growth and shortening rates, duration of attenuation phases, percentage of time spent in each phase (growth, shortening and attenuation) and catastrophe frequency. We also observed modifications in the expression level of the tumor suppressor protein phosphatase 2Ac, which has been shown to form a complex with Arl2. Finally, cell cycle progression was modified in these cells, particularly in regard to duration of telophase. In summary, alterations in Arl2 protein content were found to be associated with modifications in tubulin pools, microtubule dynamics as well as cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17188265     DOI: 10.1016/j.yexcr.2006.10.024

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  17 in total

1.  The ARL2 GTPase regulates mitochondrial fusion from the intermembrane space.

Authors:  Laura E Newman; Cara R Schiavon; Rachel E Turn; Richard A Kahn
Journal:  Cell Logist       Date:  2017-06-23

2.  Tubulin binding cofactor C (TBCC) suppresses tumor growth and enhances chemosensitivity in human breast cancer cells.

Authors:  Rouba Hage-Sleiman; Stéphanie Herveau; Eva-Laure Matera; Jean-Fabien Laurier; Charles Dumontet
Journal:  BMC Cancer       Date:  2010-04-12       Impact factor: 4.430

Review 3.  Higher order signaling: ARL2 as regulator of both mitochondrial fusion and microtubule dynamics allows integration of 2 essential cell functions.

Authors:  Joshua W Francis; Rachel E Turn; Laura E Newman; Cara Schiavon; Richard A Kahn
Journal:  Small GTPases       Date:  2016-07-11

4.  Proteomic analysis of α4β1 integrin adhesion complexes reveals α-subunit-dependent protein recruitment.

Authors:  Adam Byron; Jonathan D Humphries; Sue E Craig; David Knight; Martin J Humphries
Journal:  Proteomics       Date:  2012-07       Impact factor: 3.984

Review 5.  Faithful chaperones.

Authors:  Ewa Szolajska; Jadwiga Chroboczek
Journal:  Cell Mol Life Sci       Date:  2011-06-08       Impact factor: 9.261

6.  microRNA-214 functions as a tumor suppressor in human colon cancer via the suppression of ADP-ribosylation factor-like protein 2.

Authors:  Li-Min Long; Ben-Fu He; Guo-Qing Huang; Yong-Hong Guo; You-Shuo Liu; Ji-Rong Huo
Journal:  Oncol Lett       Date:  2014-11-28       Impact factor: 2.967

7.  MicroRNA-195 targets ADP-ribosylation factor-like protein 2 to induce apoptosis in human embryonic stem cell-derived neural progenitor cells.

Authors:  Y Zhou; H Jiang; J Gu; Y Tang; N Shen; Y Jin
Journal:  Cell Death Dis       Date:  2013-06-27       Impact factor: 8.469

8.  ADP ribosylation factor like 2 (Arl2) regulates breast tumor aggressivity in immunodeficient mice.

Authors:  Anne Beghin; Stéphane Belin; Rouba Hage-Sleiman; Rouba Hage Sleiman; Stéphanie Brunet Manquat; Sophie Goddard; Eric Tabone; Lars P Jordheim; Isabelle Treilleux; Marie-France Poupon; Jean-Jacques Diaz; Charles Dumontet
Journal:  PLoS One       Date:  2009-10-15       Impact factor: 3.240

9.  Dysregulation of ribosome biogenesis and translational capacity is associated with tumor progression of human breast cancer cells.

Authors:  Stéphane Belin; Anne Beghin; Eduardo Solano-Gonzàlez; Laurent Bezin; Stéphanie Brunet-Manquat; Julien Textoris; Anne-Catherine Prats; Hichem C Mertani; Charles Dumontet; Jean-Jacques Diaz
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

10.  The ARL2 GTPase is required for mitochondrial morphology, motility, and maintenance of ATP levels.

Authors:  Laura E Newman; Cheng-jing Zhou; Samatha Mudigonda; Alexa L Mattheyses; Eleonora Paradies; Carlo Marya Thomas Marobbio; Richard A Kahn
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.